HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 40, 37949-37954, October 4, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/40/37949    most recent M204497200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Javelaud, D. Articles by Besançon, F. Search for Related Content PubMed PubMed Citation Articles by Javelaud, D. Articles by Besançon, F. Social Bookmarking                      What's this?

Inactivation of p21^WAF1 Sensitizes Cells to Apoptosis via an Increase of Both p14^ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio^*

Delphine Javelaud and Françoise Besançon

From INSERM U365, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, France

p21^WAF1 appears to be a major determinant of the cell fate in response to anticancer therapy. It was shown previously that HCT116 human colon cancer cells growing in vitro enter a stable arrest upon DNA damage, whereas cells with a defective p21^WAF1 response undergo apoptosis. Here we report that the enhanced sensitivity of HCT116/p21^/ cells to chemotherapeutic drug-induced apoptosis correlates with an increased expression of p53 and a modification of their Bax/Bcl-2 ratio in favor of the pro-apoptotic protein Bax. Treatment of HCT116/p21^/ cells with daunomycin resulted in a reduction of the mitochondrial membrane potential and in activation of caspase-9, whereas no such changes were observed in HCT116/p21^+/+ cells, providing evidence that p21^WAF1 exerts an antagonistic effect on the mitochondrial pathway of apoptosis. Moreover, the role of p53 in activation of this pathway was demonstrated by the fact that inhibition of p53 activity by pifithrin- reduced the sensitivity of HCT116/p21^/ cells to daunomycin-induced apoptosis and restored a Bax/Bcl-2 ratio similar to that observed in HCT116p21^+/+ cells. Enhancement of p53 expression after disruption of p21^WAF1 resulted from a stabilization of p53, which correlated with an increased expression of the tumor suppressor p14^ARF, an inhibitor of the ubiquitin ligase activity of Mdm2. In accordance with the role of p14^ARF in p53 stabilization, overexpression of p14^ARF in HCT116/p21^+/+ cells resulted in a strong increase in p53 activity. Our results identify a novel mechanism for the anti-apoptotic effect of p21^WAF1 consisting in maintenance of mitochondrial homeostasis that occurs in consequence of a negative control of p14^ARF expression.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				H. M. Sankala, N. C. Hait, S. W. Paugh, D. Shida, S. Lepine, L. W. Elmore, P. Dent, S. Milstien, and S. Spiegel Involvement of Sphingosine Kinase 2 in p53-Independent Induction of p21 by the Chemotherapeutic Drug Doxorubicin Cancer Res., November 1, 2007; 67(21): 10466 - 10474. [Abstract] [Full Text] [PDF]

				M.G. Luciani, C. Campregher, and C. Gasche Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM Carcinogenesis, October 1, 2007; 28(10): 2207 - 2217. [Abstract] [Full Text] [PDF]

				P. F. Vitiello, R. J. Staversky, S. C. Gehen, C. J. Johnston, J. N. Finkelstein, T. W. Wright, and M. A. O'Reilly p21Cip1 Protection against Hyperoxia Requires Bcl-XL and Is Uncoupled from Its Ability to Suppress Growth Am. J. Pathol., June 1, 2006; 168(6): 1838 - 1847. [Abstract] [Full Text] [PDF]

				S. K. Radhakrishnan and A. L. Gartel A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity. Cancer Res., March 15, 2006; 66(6): 3264 - 3270. [Abstract] [Full Text] [PDF]

				O. W. Rokhlin, R. B. Glover, N. V. Guseva, A. F. Taghiyev, K. G. Kohlgraf, and M. B. Cohen Mechanisms of Cell Death Induced by Histone Deacetylase Inhibitors in Androgen Receptor-Positive Prostate Cancer Cells Mol. Cancer Res., February 1, 2006; 4(2): 113 - 123. [Abstract] [Full Text] [PDF]

				S. C. Kaul, S. Aida, T. Yaguchi, K. Kaur, and R. Wadhwa Activation of Wild Type p53 Function by Its Mortalin-binding, Cytoplasmically Localizing Carboxyl Terminus Peptides J. Biol. Chem., November 25, 2005; 280(47): 39373 - 39379. [Abstract] [Full Text] [PDF]

				J. C. Ghosh and D. C. Altieri Activation of p53-Dependent Apoptosis by Acute Ablation of Glycogen Synthase Kinase-3{beta} in Colorectal Cancer Cells Clin. Cancer Res., June 15, 2005; 11(12): 4580 - 4588. [Abstract] [Full Text] [PDF]

				N. G. Iyer, S.-F. Chin, H. Ozdag, Y. Daigo, D.-E. Hu, M. Cariati, K. Brindle, S. Aparicio, and C. Caldas p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels PNAS, May 11, 2004; 101(19): 7386 - 7391. [Abstract] [Full Text] [PDF]

				T. Ishii, M. Fujishiro, M. Masuda, Y. Goshima, H. Kitamura, S. Teramoto, and T. Matsuse Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells Eur. Respir. J., May 1, 2004; 23(5): 665 - 670. [Abstract] [Full Text] [PDF]

				T. Bruhl, C. Heeschen, A. Aicher, A. S. Jadidi, J. Haendeler, J. Hoffmann, M. D. Schneider, A. M. Zeiher, S. Dimmeler, and L. Rossig p21Cip1 Levels Differentially Regulate Turnover of Mature Endothelial Cells, Endothelial Progenitor Cells, and In Vivo Neovascularization Circ. Res., March 19, 2004; 94(5): 686 - 692. [Abstract] [Full Text] [PDF]

				B. R. Lawson, R. Baccala, J. Song, M. Croft, D. H. Kono, and A. N. Theofilopoulos Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity J. Exp. Med., February 17, 2004; 199(4): 547 - 557. [Abstract] [Full Text] [PDF]

				M. di Pietro, G. Marra, P. Cejka, L. Stojic, M. Menigatti, M. S. Cattaruzza, and J. Jiricny Mismatch Repair-Dependent Transcriptome Changes In Human Cells Treated with the Methylating Agent N-Methyl-N'-Nitro-N-Nitrosoguanidine Cancer Res., December 1, 2003; 63(23): 8158 - 8166. [Abstract] [Full Text] [PDF]

				T. J. Hawke, A. P. Meeson, N. Jiang, S. Graham, K. Hutcheson, J. M. DiMaio, and D. J. Garry p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1019 - C1027. [Abstract] [Full Text] [PDF]

				L. Zeng, Y. Zhang, S. Chien, X. Liu, and J. Y.-J. Shyy The Role of p53 Deacetylation in p21Waf1 Regulation by Laminar Flow J. Biol. Chem., June 27, 2003; 278(27): 24594 - 24599. [Abstract] [Full Text] [PDF]

				N. T.V. Le and D. R. Richardson Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation Carcinogenesis, June 1, 2003; 24(6): 1045 - 1058. [Abstract] [Full Text] [PDF]